Mutual Advisors LLC Has $2.09 Million Stock Position in Axon Enterprise, Inc $AXON

Mutual Advisors LLC increased its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 669.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,916 shares of the biotechnology company’s stock after acquiring an additional 2,537 shares during the quarter. Mutual Advisors LLC’s holdings in Axon Enterprise were worth $2,089,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Stone House Investment Management LLC bought a new position in shares of Axon Enterprise in the 3rd quarter valued at about $29,000. Hemington Wealth Management raised its stake in shares of Axon Enterprise by 70.8% during the second quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company’s stock worth $33,000 after buying an additional 17 shares during the last quarter. Whipplewood Advisors LLC lifted its holdings in Axon Enterprise by 192.9% in the second quarter. Whipplewood Advisors LLC now owns 41 shares of the biotechnology company’s stock valued at $34,000 after buying an additional 27 shares during the period. Darwin Wealth Management LLC bought a new position in Axon Enterprise in the second quarter valued at approximately $37,000. Finally, Root Financial Partners LLC acquired a new stake in Axon Enterprise during the 3rd quarter worth $34,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, CAO Jennifer H. Mak sold 1,134 shares of the stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $600.00, for a total transaction of $680,400.00. Following the completion of the transaction, the chief accounting officer owned 13,740 shares in the company, valued at approximately $8,244,000. This represents a 7.62% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Patrick W. Smith sold 10,000 shares of the business’s stock in a transaction dated Monday, December 8th. The shares were sold at an average price of $551.92, for a total value of $5,519,200.00. Following the completion of the sale, the chief executive officer owned 3,110,997 shares in the company, valued at approximately $1,717,021,464.24. This trade represents a 0.32% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 60,540 shares of company stock worth $34,684,738. Company insiders own 5.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on AXON. Barclays cut their price target on Axon Enterprise from $861.00 to $702.00 and set an “overweight” rating on the stock in a research note on Thursday, November 6th. The Goldman Sachs Group cut their target price on Axon Enterprise from $940.00 to $800.00 and set a “buy” rating on the stock in a research note on Wednesday, November 5th. Weiss Ratings restated a “hold (c-)” rating on shares of Axon Enterprise in a research report on Monday, December 29th. Royal Bank Of Canada started coverage on Axon Enterprise in a research note on Monday, November 17th. They issued an “outperform” rating and a $860.00 price target for the company. Finally, TD Cowen restated a “buy” rating on shares of Axon Enterprise in a report on Wednesday, November 5th. Fourteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Axon Enterprise has an average rating of “Moderate Buy” and a consensus target price of $805.71.

Axon Enterprise Stock Performance

Shares of AXON opened at $459.99 on Tuesday. The company has a debt-to-equity ratio of 0.57, a quick ratio of 2.89 and a current ratio of 3.12. Axon Enterprise, Inc has a twelve month low of $459.50 and a twelve month high of $885.91. The firm’s 50 day moving average price is $577.05 and its two-hundred day moving average price is $666.57. The firm has a market cap of $36.30 billion, a P/E ratio of 145.57, a PEG ratio of 14.57 and a beta of 1.48.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings data on Wednesday, November 5th. The biotechnology company reported $1.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.63 by ($0.46). The company had revenue of $710.64 million for the quarter, compared to the consensus estimate of $704.83 million. Axon Enterprise had a return on equity of 4.29% and a net margin of 10.05%.The firm’s revenue was up 30.6% on a year-over-year basis. During the same period in the prior year, the company earned $1.45 EPS. On average, analysts forecast that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.